Add like
Add dislike
Add to saved papers

[Analysis of Postoperative Complications and Risk Factors of Patients with Lung Cancer through Clavien-Dindo Classification].

BACKGROUND: Postoperative complications (PCs) are contributing factors to patient mortality following lung resection. In this retrospective study, the Clavien-Dindo classification was used to analyze the current incidence of PCs and identify the risk factors of different grades of PCs.

METHODS: A total of 966 lung cancer patients who underwent lobectomy in our department between June 2013 and December 2014 were retrospectively enrolled. Patients were divided into two groups depending on the occurrence of PCs. The PCs were classified into four grades through the Clavien-Dindo classification, and the related risk factors of different grades were evaluated.

RESULTS: Approximately 15.0% (145/966) of patients had PC (total incidence: 39.3%, 380/966). Among the 380 cases with PCs, the proportions of Clavien-Dindo grade I, grade II, grade III and grade IV or above complications were 6.8%, 75.3%, 15.0% and 2.9%, respectively. Binary Logistic regressions showed that preoperative forced expiratory volume in one second (FEV1), diffusion capacity for carbon monoxide of the lung (single breath)(DLco SB), and preoperative combined chronic obstructive pulmonary disease were the significant independent factors for PCs. FEV1 in preoperative pulmonary function was the significant risk factor for complications at Clavien-Dindo grade I, grade II, grade III, and above.

CONCLUSIONS: Clavien-Dindo grade II complications are the most common complications within 30 days after lung cancer lobectomy. FEV1 is closely related to the occurrence of PCs and may potentially be one of the practical variables to assess the risk of occurrence of PCs.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app